Life News reports:
Embryonic stem cell research has had troubles in animal studies with immune system rejection issues and the formation of tumors, but one leading biotech firm says it’s going to try experiments on humans this Spring. The chief executive of biotech Geron said Monday that trials with embryonic stem cells await FDA approval.
